Siguazodan

CAS: 115344-47-3

Ref. 3D-QEA34447

Información del producto

• Nombre: Siguazodan
• Sinónimos: 1-Cyano-2-Methyl-3-[4-(4-Methyl-6-Oxo-1,4,5,6-Tetrahydropyridazin-3-Yl)Phenyl]Guanidine, Guanidine, N-cyano-N′-methyl-N′′-[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-, N-Cyano-N'-Methyl-N'-[4-(1,4,5,6-Tetrahydro-4-Methyl-6-Oxo-3-Pyridazinyl)Phenyl]Guanidine, N-Cyano-Nmethyl-N��-[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]guanidine, Siguazodan (SKF 94836), Siguazodan, N-Cyano-Nμ-methyl-N-[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]guanidine, Sk And F-94836, Skf 94836

Descripción

Siguazodan is a phosphodiesterase inhibitor that is used for the treatment of congestive heart failure and bowel disease. Siguazodan inhibits the activity of cyclic nucleotide phosphodiesterases, which are enzymes that regulate the concentration of cyclic AMP (cAMP) in cells. It has anti-inflammatory properties and can be used to inhibit the bronchoconstrictor response. Siguazodan also inhibits phosphodiesterase-4 (PDE4), an enzyme that degrades cAMP, increasing intracellular concentrations and causing bronchodilation.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 284.32 g/mol
• Fórmula: C₁₄H₁₆N₆O
• Pureza: Min. 95%